Yutaka Kawakami, Chair
Japanese Cancer Association Conflict of Interest Committee
Cancer research based on industrial-academic cooperation not only returns to society the results obtained by researchers executing their scientific and ethical responsibilities (public benefit), but also sometimes generates money, standing and concessions, etc., that are acquired by individual researchers in association with such industrial-academic cooperation (personal gains). The situation where these two types of interests occur at the same time in regard to an individual researcher is known as gconflict of interesth. In order to promote industrial-academic cooperation, the occurrence of conflicts of interest is unavoidable, but it is also possible that adverse effects such as the loss of credibility in research results, the loss of trust by society, or dangers to clinical test subjects will occur too.
Consequently, the Japanese Cancer Association started the submission and disclosure of matters of conflict of interest by officers of the Japanese Cancer Association, presenters at lecture meetings hosted by the Japanese Cancer Association such as the annual meeting of the association, conferences, symposiums, and public lecture meetings (hereinafter referred to as gscientific meetings, etc.h), and contributors of articles to Cancer Science in order to appropriately promote publication, dissemination and enlightenment of research results while maintaining neutrality and fairness and to contribute to advancement of cancer research. (The submission and disclosure of already existing matters of conflict of interest is also sometimes called for.)
From April 2011, the Japanese Cancer Association will receive self-reports on conflicts of interest not only in clinical research, but in all research, including basic research, in association with the revision of the gJapanese Cancer Association (JCA) Detailed Regulations on the Handling of Conflict of Interesth of 2010. For details, please see the following guideline, detailed regulations and Q&A on the detailed regulations.
The newest version will be uploaded soon.
* The guideline follows the guideline jointly formulated by the Japanese Society of Medical Oncology and the Japan Society of Clinical Oncology.
(Permission has been obtained from both societies in regard to use of the guideline.)
From April 2011, researchers contributing articles to Cancer Science, the official journal of the Japanese Cancer Association will have to disclose any COI situations in line with the Cancer Science COI Policy. Researchers contributing articles are asked to read the following COI Policy and disclose any COI situations in line with the guide on article contribution screen.
Japanese Cancer Association Executive Office